| abstract |
The invention relates to substituted heterocyclic compounds of general formula (II), compositions containing said compounds, and the use of said compounds and compositions for epigenetic regulation by inhibiting bromodomain-mediated recognition of acetyllysine regions of proteins, such as histones. These compositions and methods can be used to treat cancer and neoplastic diseases. |